McLane J. Watson

2.6k total citations · 2 hit papers
10 papers, 1.4k citations indexed

About

McLane J. Watson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, McLane J. Watson has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in McLane J. Watson's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). McLane J. Watson is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). McLane J. Watson collaborates with scholars based in United States, Denmark and China. McLane J. Watson's co-authors include Greg M. Delgoffe, Ashley V. Menk, Kristin DePeaux, Amanda C. Poholek, Paolo Vignali, Ronal M. Peralta, Natalie Rittenhouse, Dario A.A. Vignali, Stephanie Grebinoski and Steven J. Mullett and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

McLane J. Watson

10 papers receiving 1.4k citations

Hit Papers

Metabolic support of tumour-infiltrating regulatory T cel... 2021 2026 2022 2024 2021 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
McLane J. Watson United States 8 791 561 489 439 164 10 1.4k
Ronal M. Peralta United States 7 875 1.1× 578 1.0× 558 1.1× 507 1.2× 187 1.1× 12 1.6k
Paolo Vignali United States 8 1.1k 1.4× 710 1.3× 697 1.4× 595 1.4× 220 1.3× 17 2.0k
Stephanie Grebinoski United States 7 548 0.7× 353 0.6× 383 0.8× 327 0.7× 120 0.7× 9 1.0k
Xiaoqian Zhang China 6 824 1.0× 411 0.7× 874 1.8× 636 1.4× 160 1.0× 12 1.7k
Chahrazade Kantari‐Mimoun France 10 766 1.0× 680 1.2× 388 0.8× 186 0.4× 140 0.9× 11 1.3k
Yosra Messai France 13 486 0.6× 505 0.9× 411 0.8× 453 1.0× 108 0.7× 23 1.2k
Miriam R. Fein United States 5 769 1.0× 492 0.9× 336 0.7× 144 0.3× 210 1.3× 8 1.2k
B. Rhodes Ford United States 8 604 0.8× 391 0.7× 249 0.5× 212 0.5× 93 0.6× 10 969
Jiri Keirsse Belgium 12 990 1.3× 525 0.9× 412 0.8× 187 0.4× 94 0.6× 19 1.3k
Jason Hatakeyama United States 13 702 0.9× 390 0.7× 678 1.4× 176 0.4× 83 0.5× 17 1.3k

Countries citing papers authored by McLane J. Watson

Since Specialization
Citations

This map shows the geographic impact of McLane J. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by McLane J. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites McLane J. Watson more than expected).

Fields of papers citing papers by McLane J. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by McLane J. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by McLane J. Watson. The network helps show where McLane J. Watson may publish in the future.

Co-authorship network of co-authors of McLane J. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of McLane J. Watson. A scholar is included among the top collaborators of McLane J. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with McLane J. Watson. McLane J. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Longo, Joseph, McLane J. Watson, Kelsey S. Williams, Ryan D. Sheldon, & Russell G. Jones. (2025). Nutrient allocation fuels T cell-mediated immunity. Cell Metabolism. 37(12). 2311–2322. 3 indexed citations
2.
DePeaux, Kristin, Dayana B. Rivadeneira, Konstantinos Lontos, et al.. (2023). An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment. The Journal of Experimental Medicine. 220(10). 20 indexed citations
3.
Lontos, Konstantinos, Yiyang Wang, Andrew Frisch, et al.. (2023). Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors. Journal for ImmunoTherapy of Cancer. 11(3). e006522–e006522. 59 indexed citations
4.
Vignali, Paolo, Kristin DePeaux, McLane J. Watson, et al.. (2022). Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nature Immunology. 24(2). 267–279. 163 indexed citations breakdown →
5.
Kaymak, Irem, Katarzyna M. Luda, H. Eric, et al.. (2022). Carbon source availability drives nutrient utilization in CD8+ T cells. Cell Metabolism. 34(9). 1298–1311.e6. 80 indexed citations
6.
Watson, McLane J., Paolo Vignali, Steven J. Mullett, et al.. (2021). Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 591(7851). 645–651. 817 indexed citations breakdown →
7.
Watson, McLane J., Kasturi Banerjee, Sander B. Frank, et al.. (2021). Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation. Oncogene. 40(18). 3260–3272. 13 indexed citations
8.
Vignali, Paolo, Kristin DePeaux, McLane J. Watson, et al.. (2020). 512 Terminally exhausted CD8+ T cells potentiate the tolerogenic tumor microenvironment as functional suppressors. SHILAP Revista de lepidopterología. A315.1–A315. 2 indexed citations
9.
Menk, Ashley V., Nicole E. Scharping, Dayana B. Rivadeneira, et al.. (2018). 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. The Journal of Experimental Medicine. 215(4). 1091–1100. 209 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026